PATENT CLAIM ANALYSIS

Application Number: 15957625
Application Type: Utility
Filing Date: 2018-04
Publication Date: 2018-08
Patent Classification: ["514", "044000"]

Abstract:
A method of treating a T cell-mediated inflammatory autoimmune disease by administering to an individual in need thereof an immunogenic composition comprising a recombinant construct of a nucleic acid sequence encoding heat shock protein 90 (HSP 90), or an active fragment thereof, wherein the nucleic acid sequence is operatively linked to one or more transcription control sequences. The disease is other than insulin dependent diabetes mellitus (IDDM) or rheumatoid arthritis. The administering of the immunogenic composition results in a shift of the immune response to a Th2 response, thereby treating the disease.

Claim (Index 33):
The method of  claim 27 , wherein the composition is administered in an amount to provide about 0.1 \u03bcg/kg body weight to about 10 \u03bcg/kg body weight of the nucleic acid molecule encoding the mammalian HSP90, or an active fragment thereof to the individual.

Metadata:
- Claim Count in Document: 47.0
- Percentile: 91.0
- Lexical Diversity: 1.56923
- Patent Class: 514.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['15012540', '14507648', '13293722', '12396401', '11813333']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.8951794947514562
- 35 USC 102 Novelty (BERT): 0.7335679070998575
- Combined Prediction Score: 0.8790183359862964
- Mean Citation Score: 797.3803999999999
- Max Citation Score: 894.06055
- Similarity Product: 807.3093362392276

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 0
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test